Teva Albuterol Inhaler Recall: Impurities May Cause Harm
Teva Pharmaceuticals USA recalls Albuterol Sulfate Inhalation Solution with high impurities. Products may contain unsafe levels of related compound D. Check lot numbers for affected batches.
Lower-risk recall
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
Contact the company
What happened, in plain English
Teva Pharmaceuticals USA is recalling Albuterol Sulfate Inhalation Solution due to high levels of an impurity called related compound D. This could pose a risk to users, especially those with respiratory conditions who rely on the inhaler. Read more at govinfonow.com/recall/41428-teva-albuterol-inhaler-recall-impurities-may-cause-harm.
Source Summary by GovInfoNow · govinfonow.com/recall/41428-teva-albuterol-inhaler-recall-impurities-may-cause-harm · Updated October 7, 2026 · FDA enforcement record: FDA #D-1039-2017
Cite this page
“Teva Albuterol Inhaler Recall: Impurities May Cause Harm.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41428-teva-albuterol-inhaler-recall-impurities-may-cause-harm. Based on FDA recall #D-1039-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1039-2017%22&limit=1).
Why it’s dangerous
The inhaler contains high levels of a related compound D that exceeds safety specifications. This impurity could potentially cause adverse effects, though the risk is not severe enough to cause serious injury in normal use.
Who’s affected
People with prescriptions for this inhaler, particularly those with asthma or other respiratory conditions. Those using the product without a prescription are not affected.
How to tell if you have this one
Check the product label for the lot numbers listed: GA60206, GA60207 (exp 08/17), GA60283, GA60284 (exp 09/17), and other specific batch numbers. The product is a 0.021% Albuterol Sulfate Inhalation Solution in 5 pouches of 5 x 3mL vials.
- Brand
Teva Pharmaceuticals USA- Category
Drug
What to do — step by step
Check Product Lot Number
Look for the lot numbers on the vial packaging: GA60206, GA60207, GA60283, GA60284, and other specific batch numbers listed in the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1039-2017 (July 25, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1039-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.